Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-25 @ 7:10 PM
Study NCT ID:
NCT00415532
Status:
COMPLETED
Last Update Posted:
2022-11-08
First Post:
2006-12-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2008-11-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-05-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-21
First Submit QC Date:
None
Study First Post Date:
2006-12-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-10-01
Results First Submit QC Date:
None
Results First Post Date:
2013-07-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-04
Last Update Post Date:
2022-11-08
Last Update Post Date Type:
ACTUAL